Compare AST SpaceMobile Inc (ASTS) vs Becton Dickinson and Co (BDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AST SpaceMobile Inc vs Becton Dickinson and Co — how do they compare? AST SpaceMobile Inc trades at $67.77 (market cap $21.90B), while Becton Dickinson and Co trades at $154.29 (market cap $41.87B). The key difference: Becton Dickinson and Co is the larger of the two by market cap, and Becton Dickinson and Co pays a 2.76% dividend while AST SpaceMobile Inc pays none. Which is the better fit depends on your goals.
| ASTS | BDX | |
|---|---|---|
Market Cap | $21.90B | $41.87B |
Sector | Media | Health |
52-Week High | $133.09 | $185.39 |
52-Week Low | $36.91 | $135.49 |
Enterprise Value | $21.87B | $58.33B |
Dividend Yield | — | 2.76% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AST SpaceMobile (ASTS) trades at $67.58, down 7.83% amid a bearish technical signal and negative earnings trends. The company reported a net loss of $341.94M on $70.92M revenue in 2025, with a P/S ratio of 235.37 indicating high valuation relative to sales. Recent news highlights volatility driven by satellite launch developments and competition in the space connectivity sector.
Outlook hinges on execution of satellite deployments and partnerships with AT&T and Verizon, offering growth potential but facing significant execution and funding risks. High cash burn and negative margins underscore the speculative nature, with analyst consensus target at $90.33 suggesting cautious optimism if operational milestones are met.
BDX trades at $153.83, up 1.24% today, with a mixed technical picture showing a bearish overall signal but neutral oscillators. The company has consistently beaten earnings expectations in recent quarters, with Q2 2026 EPS expected at $3.14. Revenue growth is steady, reaching $21.84B in 2025, though net income margin compressed to 5.12%. Analyst consensus is a 'Hold' with a $173.40 price target, indicating modest upside. Recent news highlights product innovation, including new medical laser systems.
The outlook for BDX is cautiously optimistic, supported by earnings beats and strategic product launches in the medical technology sector. Key opportunities include exposure to growing demand for GLP-1-related equipment and a solid dividend history. Risks involve hospital spending caution, rising debt levels, and competitive pressures. The stock's valuation at a P/E of 26.52 requires sustained earnings growth to justify further gains.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AST SpaceMobile Inc
AST SpaceMobile Inc is a satellite designer and manufacturer. The company is building the global cellular broadband network in space to operate directly with standard, unmodified mobile devices based on extensive IP and patent portfolio. AST is on a mission to eliminate the connectivity gaps faced by mobile subscribers and finally bring broadband to the billions who remain unconnected.
Read more on ASTS →About Becton Dickinson and Co
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →
